Efficacy and safety of 8 weeks versus 12 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin in patients with hepatitis C virus genotype 1 mono-infection and HIV/hepatitis C virus co-infection (C-WORTHY): a randomised, open-label phase 2 trial
Sulkowski, Mark, Dr Prof, Hezode, Christophe, Prof, Gerstoft, Jan, Prof, Vierling, John M, Prof, Mallolas, Josep, MD PhD, Pol, Stanislas, Prof, Kugelmas, Marcelo, MD, Murillo, Abel, MD, Weis, Nina, PhD, Nahass, Ronald, Prof, Shibolet, Oren, MD, Serfaty, Lawrence, MD, Bourliere, Marc, MD, DeJesus, Edwin, MD, Zuckerman, Eli, Prof, Dutko, Frank, PhD, Shaughnessy, Melissa, MS, Hwang, Peggy, PhD, Howe, Anita Y M, PhD, Wahl, Janice, MD, Robertson, Michael, MD, Barr, Eliav, MD, Haber, Barbara, MD
Published in The Lancet (British edition) (21.03.2015)
Published in The Lancet (British edition) (21.03.2015)
Get full text
Journal Article
Boceprevir versus placebo with pegylated interferon alfa-2b and ribavirin for treatment of hepatitis C virus genotype 1 in patients with HIV: a randomised, double-blind, controlled phase 2 trial
Sulkowski, Mark, Prof, Pol, Stanislas, Prof, Mallolas, Josep, MD, Fainboim, Hugo, MD, Cooper, Curtis, MD, Slim, Jihad, MD, Rivero, Antonio, MD, Mak, Carmen, PhD, Thompson, Seth, PhD, Howe, Anita YM, PhD, Wenning, Larissa, PhD, Sklar, Peter, MD, Wahl, Janice, MD, Greaves, Wayne, Dr
Published in The Lancet infectious diseases (01.07.2013)
Published in The Lancet infectious diseases (01.07.2013)
Get full text
Journal Article
Dual treatment with lopinavir–ritonavir plus lamivudine versus triple treatment with lopinavir–ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): a randomised, open-label, non-inferiority trial
Arribas, José R, Dr, Girard, Pierre-Marie, MD, Landman, Roland, MD, Pich, Judit, PharmD, Mallolas, Josep, MD, Martínez-Rebollar, María, MD, Zamora, Francisco X, MD, Estrada, Vicente, MD, Crespo, Manuel, MD, Podzamczer, Daniel, MD, Portilla, Joaquín, MD, Dronda, Fernando, MD, Iribarren, José A, MD, Domingo, Pere, MD, Pulido, Federico, MD, Montero, Marta, MD, Knobel, Hernando, MD, Cabié, André, Prof, Weiss, Laurence, Prof, Gatell, José M, Prof
Published in The Lancet infectious diseases (01.07.2015)
Published in The Lancet infectious diseases (01.07.2015)
Get full text
Journal Article
Efficacy and safety of grazoprevir (MK-5172) and elbasvir (MK-8742) in patients with hepatitis C virus and HIV co-infection (C-EDGE CO-INFECTION): a non-randomised, open-label trial
Rockstroh, Jürgen K, Nelson, Mark, Katlama, Christine, Lalezari, Jay, Mallolas, Josep, Bloch, Mark, Matthews, Gail V, Saag, Michael S, Zamor, Philippe J, Orkin, Chloe, Gress, Jacqueline, Klopfer, Stephanie, Shaughnessy, Melissa, Wahl, Janice, Nguyen, Bach-Yen T, Barr, Eliav, Platt, Heather L, Robertson, Michael N, Sulkowski, Mark
Published in The lancet HIV (01.08.2015)
Published in The lancet HIV (01.08.2015)
Get more information
Journal Article